相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival
Afroditi Nanou et al.
BRITISH JOURNAL OF CANCER (2020)
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
Vincenza Conteduca et al.
MOLECULAR CANCER THERAPEUTICS (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
Direct comparison of size-dependent versus EpCAM-dependent CTC enrichment at the gene expression and DNA methylation level in head and neck squamous cell carcinoma
Martha Zavridou et al.
SCIENTIFIC REPORTS (2020)
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy
Katharina Kessel et al.
THERANOSTICS (2020)
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer
Adam Sharp et al.
EUROPEAN UROLOGY (2019)
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer
Channing J. Paller et al.
PROSTATE (2019)
Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes
Mohammed Nimir et al.
CELLS (2019)
Applications of liquid biopsies for cancer
Austin K. Mattox et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
Klaus Pantel et al.
CLINICAL CHEMISTRY (2019)
Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management
Anjui Wu et al.
CLINICAL CHEMISTRY (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies
Emma E. van der Toom et al.
NATURE REVIEWS UROLOGY (2019)
Expression pattern of androgen receptors, AR-V7 and AR-567es, in circulating tumor cells and paired plasma-derived extracellular vesicles in metastatic castration resistant prostate cancer
Areti Strati et al.
ANALYST (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and KRAS Point Mutations in Circulating Tumor Cells
Amin El-Heliebi et al.
CLINICAL CHEMISTRY (2018)
RNA Profiles of Circulating Tumor Cells and Extracellular Vesicles for Therapy Stratification of Metastatic Breast Cancer Patients
Corinna Keup et al.
CLINICAL CHEMISTRY (2018)
Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies
Martha Zavridou et al.
CLINICAL CHEMISTRY (2018)
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
Afroditi Nanou et al.
Oncotarget (2018)
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
Landmarks in prostate cancer
Niranjan J. Sathianathen et al.
NATURE REVIEWS UROLOGY (2018)
Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients
Athina Markou et al.
CLINICAL CHEMISTRY (2018)
Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting
Parvez M. Lokhandwala et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA
Lydia Giannopoulou et al.
ONCOTARGET (2017)
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
A. Strati et al.
ANNALS OF ONCOLOGY (2017)
Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
Vanesa Nogales et al.
ONCOTARGET (2016)
Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
Tobias M. Gorges et al.
CLINICAL CHEMISTRY (2016)
Gene expression profiling and DNA methylation analyses of CTCs
Evi S. Lianidou
MOLECULAR ONCOLOGY (2016)
Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer
Tobias M. Gorges et al.
ONCOTARGET (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis et al.
JAMA ONCOLOGY (2015)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
Gabriele Zoppoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor Cells
Maria Chimonidou et al.
CLINICAL CHEMISTRY (2011)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
分享论文
